Cure Rare Disease Welcomes Brittany Stineman as New Leader
Cure Rare Disease, a nonprofit biotechnology organization dedicated to improving treatments for rare and genetic diseases, has proudly appointed Brittany Stineman as its new Chief Advancement Officer. This appointment comes at a pivotal moment for the organization as it aims to advance several ultra-rare disease therapies into clinical stages.
Turning Personal Tragedy Into a Mission
Brittany Stineman's journey is profoundly personal; as a mother who faced the harrowing experience of her son’s rare disease, she has transformed her challenges into a powerful mission to help others. Her advocacy and determination to find effective solutions have already made a significant impact, including the successful development of a gene therapy that entered clinical trials.
A Passion for Collaboration and Community Support
In her own words, Stineman expressed, “I am deeply honored to join Cure Rare Disease and continue moving science forward for families impacted by rare diseases.” Her understanding of the challenges faced by these families informs her approach, emphasizing the urgency of collaboration, innovation, and community involvement in securing critical funding for life-saving treatments.
The Role of Chief Advancement Officer
As the Chief Advancement Officer, Stineman is poised to lead initiatives that foster grassroots campaigns and engage significant donors. Her focus will also be on forging partnerships with companies to assure vital research funding and treatment development, driving the organization’s mission further than ever before.
Inspiring Hope and Resilience
“Brittany’s story exemplifies the hope and resilience needed when facing the challenges of rare diseases,” stated Richard Horgan, CEO of Cure Rare Disease. He believes that Stineman’s firsthand experience with these issues will not only enrich the organization's efforts but also serve as a beacon of hope for families who find themselves in desperate situations without viable treatment options.
Stineman’s innovative leadership promises to inspire action and mobilize resources efficiently. Her success in fundraising and advocacy will be essential as Cure Rare Disease continues to push the boundaries of what's possible in developing therapies that have the potential to transform lives.
For more information about Cure Rare Disease and its mission, interested individuals can visit the organization’s website and stay updated on their initiatives and advancements.
About Cure Rare Disease
Cure Rare Disease is a 501(c)(3) nonprofit biotechnology organization that strives to create advanced therapies for individuals with ultra-rare diseases. Based in Woodbridge, CT, the organization works collaboratively with forward-thinking families, scientists, and supporters to foster an innovative ecosystem that navigates the inherent challenges of existing medical models. The goal is to bring life-saving genetic technologies from research to clinical application, fundamentally changing the options available for patients suffering from rare conditions.
Frequently Asked Questions
What is Cure Rare Disease?
Cure Rare Disease is a nonprofit biotechnology organization dedicated to developing treatments for rare and genetic diseases.
Who is Brittany Stineman?
Brittany Stineman is the newly appointed Chief Advancement Officer at Cure Rare Disease, advocating for better treatment solutions.
Why is Stineman's appointment significant?
Her appointment is significant because of her personal experience with rare diseases and her proven ability to mobilize resources for critical initiatives.
What is the mission of Cure Rare Disease?
The mission is to advance therapeutic options for individuals with ultra-rare diseases through innovative research and community support.
How can someone support Cure Rare Disease?
Individuals can support Cure Rare Disease by participating in campaigns, donating, and spreading awareness about rare diseases.
